Quotes with Resistance & Support

Market Information

Strides Arcolab receives USFDA approval for 2 more products

This article was posted on Sep 2, 2008 and is filed under Press Releases

Strides Arcolab Limited (“Strides”) today announced receipt of 2 ANDA approvals for Dexamethasone Injection USP, 4mg/ml, (1ml Single-dose Vials, 20mg /5 ml, 120 mg /30 ml Multipledose Vials) and Dexamethasone Sodium Phosphate Injection USP, 10 mg /ml, (10 ml Multiple-dose Vials).

The products are licensed to Akorn-Strides, LLC, which is a Joint Venture that was formed in 2004 by Akorn Inc [NASDAQ: AKRX] and Strides Arcolab Limited [NSE:STAR, BSE: 532531] Ravi Seth, Chief Executive Officer- International Operations of Strides stated: We are pleased to announce that the Akorn Strides partnership has now received eleven ANDA approvals of the 18 filed till date and commercialization in case of some of these products has already commenced effective Q3, 2008.

Tags: calls, daytrading, free calls, intraday, tips

Note: The Credit of this post goes to the original witters of this post and not to NSEGUIDE

Similar Posts:

Email this Post to your friends

Breakouts

+ve » Positive / -ve » Negative

+ve 30 DMA 50 DMA 150 DMA 200 DMA

-ve 30 DMA 50 DMA 150 DMA 200 DMA

Latest Query

Post my query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam

Status: Awaiting reply

Market Stats

Search Our Archives

Research Desk

Stocks Trading above their 50 day moving average - DMA In Stock Research
Download free Ebooks based on Technical Analysis In Personal Training
TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
Charting Pathsala - Your guide to Techincals In Technical Analysis

Latest Investment Idea

Recent Comments

Theories are private property, but truth is common stock - Charles Caleb Colton

Disclaimer

The calls given here are My Personal views, Trading or investing in stocks is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. NSEGUIDE will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal or corporate ownership, may influence or factor into an expert’s stock analysis or opinion.

All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation

Usage

The Stock calls recommended by NSEGUIDE can be used by you to invest & share it with your friends, but you are not allowed to publish it on your own or some website/blog without prior permission.

Recommend Site to your friends

Suggestions?

This is YOUR site, so if you have suggestions or feedback on how we can improve it for you, please feel free to speak up! We will try our best to keep up with it!

Make a Suggestion